+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Amgen Inc. - logo

Amgen is an international biotechnology company based in California, USA. Amgen is committed to using their experience in human genetics and biologics manufacturing to create innovative treatments for life threatening diseases particularly in areas of unmet medical need where limited treatment options exist. Amgen manufactures a wide range of therapeutic products including Aranesp, Corlanor, Neulasta and Prolia.

From
Ibuprofen Arginine API Market - Global Forecast to 2030 - Product Thumbnail Image

Ibuprofen Arginine API Market - Global Forecast to 2030

  • Report
  • August 2025
  • 194 Pages
  • Global
From
Drugs for Hormonal Replacement Therapy Market Report 2025 - Product Thumbnail Image

Drugs for Hormonal Replacement Therapy Market Report 2025

  • Report
  • September 2025
  • 250 Pages
  • Global
From
Biosimilar Monoclonal Antibodies (mAbs) Market 2021-2025 - Product Thumbnail Image

Biosimilar Monoclonal Antibodies (mAbs) Market 2021-2025

  • Report
  • July 2021
  • 120 Pages
  • Global
From
Trastuzumab Biosimilars Market - Global Forecast 2025-2032 - Product Thumbnail Image

Trastuzumab Biosimilars Market - Global Forecast 2025-2032

  • Report
  • November 2025
  • 188 Pages
  • Global
From
From
From
Renal Cell Carcinoma - Pipeline Insight, 2025 - Product Thumbnail Image

Renal Cell Carcinoma - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Trastuzumab Biosimilars Market Report 2025 - Product Thumbnail Image

Trastuzumab Biosimilars Market Report 2025

  • Report
  • April 2025
  • 175 Pages
  • Global
From
Clobetasol Propionate API Market - Global Forecast to 2030 - Product Thumbnail Image

Clobetasol Propionate API Market - Global Forecast to 2030

  • Report
  • August 2025
  • 182 Pages
  • Global
From
From
From
Hemophilia Treatment - Global Strategic Business Report - Product Thumbnail Image

Hemophilia Treatment - Global Strategic Business Report

  • Report
  • December 2025
  • 476 Pages
  • Global
From
Monoclonal Antibody Collaboration and Licensing Deals 2019-2025 - Product Thumbnail Image

Monoclonal Antibody Collaboration and Licensing Deals 2019-2025

  • Report
  • November 2025
  • 400 Pages
  • Global
From
Loading Indicator